CoChat

SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation

Open access
Uza, Norimitsu, Nakase, Hiroshi, Yamamoto, Shuji, Yoshino, Takuya, Takeda, Yasuhiro, Ueno, Satoru, Inoue, Satoko, Mikami, Sakae, Matsuura, Minoru, Shimaoka, Takeshi, Kume, Noriaki, Minami, Manabu, Yonehara, Shin, Ikeuchi, Hiroki, Chiba, Tsutomu · 2011 · Gut
Cited by 43

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background and aims: Inflammatory bowel disease (IBD) is initiated and perpetuated by a dysregulated immune response to unknown environmental antigens such as luminal bacteria in genetically susceptible hosts. SR-PSOX/CXCL16, a scavenger receptor that binds phosphatidylserine and oxidised lipoprotein, has both phagocytic activity and chemotactic properties. The aim of this study was to investigate the role of SR-PSOX/CXCL16 in patients with IBD and experimental murine colitis. Methods: The serum levels of SR-PSOX/CXCL16 were measured in patients with IBD. The roles of SR-PSOX/CXCL16 in phagocytosis of bacterial components and cytokine production by macrophages from wild-type (WT) and SR-PSOX/CXCL16 knockout (KO) mice were assessed. Colitis was induced by administering dextran sulfate sodium (DSS) to WT and SR-PSOX/CXCL16 KO mice. Colonic inflammation was analysed by clinical, histological and immunological parameters. Finally, the effect of a monoclonal antibody (mAb) to SR-PSOX/CXCL16 on DSS-induced colitis and trinitrobenzene sulfonic acid-induced colitis models was evaluated. Results: Serum levels of SR-PSOX/CXCL16 correlated significantly with the disease activity of patients with IBD. Ex vivo experiments showed that SR-PSOX/CXCL16 was involved in both phagocytosis of bacterial antigens and the T helper 1 immune response through the production of interleukin 12 and interferon γ. In vivo murine experiments demonstrated the upregulated gene expression of SR-PSOX/CXCL16 in inflamed colonic tissues and the predominant expression of SR-PSOX/CXCL16 on macrophages. SR-PSOX/CXCL16 KO mice were less susceptible to colonic inflammation than were their WT littermates. Administration of SR-PSOX/CXCL16 mAb ameliorated the condition in the two different experimental colitis models. Conclusions: SR-PSOX/CXCL16 plays a critical role in colonic inflammation and could be a potential therapeutic target for patients with IBD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gut.2010.221879

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 43

Metadata

Authors
Uza, N., Nakase, H., Yamamoto, S., Yoshino, T., Takeda, Y., Ueno, S., Inoue, S., Mikami, S., Matsuura, M., Shimaoka, T., Kume, N., Minami, M., Yonehara, S., Ikeuchi, H., & Chiba, T.
Venue
Gut
Publisher
BMJ
Published
2011-04-06
Volume
60
Issue
11
Pages
1494-1505
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2170260989
Cited by
43
References
3
FWCI
2.56
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation. https://app.cochat.ai/papers/10.1136/gut.2010.221879
The paper
Uza, N., Nakase, H., Yamamoto, S., Yoshino, T., Takeda, Y., Ueno, S., Inoue, S., Mikami, S., Matsuura, M., Shimaoka, T., Kume, N., Minami, M., Yonehara, S., Ikeuchi, H., & Chiba, T. (2011). SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation. Gut. https://doi.org/10.1136/gut.2010.221879

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.